Literature DB >> 21737126

Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.

R D Lee1, D A Barcel, J C Williams, J G Wang, J C Boles, D A Manly, N S Key, N Mackman.   

Abstract

INTRODUCTION: Elevated levels of tissue factor positive (TF(+)) microparticles (MPs) are observed in plasma from a variety of patients with an increased risk of thrombosis. We and others have described the measurement of TF activity in MPs isolated from plasma. The aim of this study was to investigate the effects of pre-analytical and analytical variables on TF activity of MPs isolated from blood of healthy volunteers either untreated or treated ex vivo with bacterial lipopolysaccharide.
MATERIALS AND METHODS: We evaluated the following parameters: use of different centrifugation speeds to isolate the MPs; comparison of TF activity of MPs isolated from platelet poor plasma versus platelet free plasma; effect of freeze/thaw on MP TF activity; and comparison of the MP TF activity assay with the measurement of TF protein by ELISA or flow cytometry.
RESULTS: MPs prepared from platelet poor plasma by centrifugation at 20,000×g or 100,000×g for 15 minutes had similar levels of TF activity. However, significantly less TF activity was found in MPs isolated from platelet free plasma compared with platelet poor plasma. Interestingly, freeze/thawing of the plasma showed donor to donor variation in MP TF activity, with a moderate increase in some individuals.
CONCLUSION: TF(+) MPs can be quantitatively isolated from platelet poor or platelet free plasma by centrifugation at 20,000×g for 15 minutes. Measurement of MP TF activity in plasma may be used to detect a prothrombotic state in patients with various diseases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737126      PMCID: PMC3272762          DOI: 10.1016/j.thromres.2011.06.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  33 in total

1.  Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

Authors:  R A Fleck; L V Rao; S I Rapaport; N Varki
Journal:  Thromb Res       Date:  1990-07-15       Impact factor: 3.944

2.  Measuring circulating cell-derived microparticles.

Authors:  W Jy; L L Horstman; J J Jimenez; Y S Ahn; E Biró; R Nieuwland; A Sturk; F Dignat-George; F Sabatier; L Camoin-Jau; J Sampol; B Hugel; F Zobairi; J M Freyssinet; S Nomura; A S Shet; N S Key; R P Hebbel
Journal:  J Thromb Haemost       Date:  2004-10       Impact factor: 5.824

3.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors:  T A Drake; J H Morrissey; T S Edgington
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.

Authors:  S A Gregory; J H Morrissey; T S Edgington
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

5.  Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.

Authors:  U Rauch; D Bonderman; B Bohrmann; J J Badimon; J Himber; M A Riederer; Y Nemerson
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

6.  Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.

Authors:  R J Berckmans; R Nieuwland; A N Böing; F P Romijn; C E Hack; A Sturk
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

7.  Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.

Authors:  E Biró; K N Sturk-Maquelin; G M T Vogel; D G Meuleman; M J Smit; C E Hack; A Sturk; R Nieuwland
Journal:  J Thromb Haemost       Date:  2003-12       Impact factor: 5.824

8.  Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.

Authors:  Vladimir Y Bogdanov; Viji Balasubramanian; James Hathcock; Oana Vele; Mark Lieb; Yale Nemerson
Journal:  Nat Med       Date:  2003-03-24       Impact factor: 53.440

9.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

Authors:  Arun S Shet; Omer Aras; Kalpna Gupta; Mathew J Hass; Douglas J Rausch; Nabil Saba; Louann Koopmeiners; Nigel S Key; Robert P Hebbel
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

10.  Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.

Authors:  Omer Aras; Arun Shet; Ronald R Bach; Jessica L Hysjulien; Arne Slungaard; Robert P Hebbel; Gines Escolar; Bernd Jilma; Nigel S Key
Journal:  Blood       Date:  2004-02-26       Impact factor: 22.113

View more
  39 in total

1.  Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand.

Authors:  Vanessa Valdes; Michael A Nardi; Lindsay Elbaum; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

2.  Isolation and phenotypic characteristics of microparticles in acute respiratory distress syndrome.

Authors:  Hongxia Li; Xiangyu Meng; Yue Gao; Shaohua Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.

Authors:  B N Yamaja Setty; Nigel S Key; A Koneti Rao; Suhita Gayen-Betal; Suba Krishnan; Carlton D Dampier; Marie J Stuart
Journal:  Br J Haematol       Date:  2012-02-24       Impact factor: 6.998

4.  Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculome.

Authors:  Silvia H De Paoli; Tseday Z Tegegn; Oumsalama K Elhelu; Michael B Strader; Mehulkumar Patel; Lukas L Diduch; Ivan D Tarandovskiy; Yong Wu; Jiwen Zheng; Mikhail V Ovanesov; Abdu Alayash; Jan Simak
Journal:  Cell Mol Life Sci       Date:  2018-02-09       Impact factor: 9.261

Review 5.  Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.

Authors:  Ying Wang; Li-ming Chen; Ming-lin Liu
Journal:  Acta Pharmacol Sin       Date:  2014-03-10       Impact factor: 6.150

6.  Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.

Authors:  Anna K Kopec; Alfred P Spada; Patricia C Contreras; Nigel Mackman; James P Luyendyk
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

7.  Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients.

Authors:  Yohei Hisada; Charlotte Thålin; Staffan Lundström; Håkan Wallén; Nigel Mackman
Journal:  Thromb Res       Date:  2018-03-07       Impact factor: 3.944

8.  Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgery.

Authors:  L Ay; J Thaler; J-M Brix; G H Schernthaner; C Ay; I Pabinger; G Schernthaner
Journal:  Int J Obes (Lond)       Date:  2015-12-01       Impact factor: 5.095

9.  Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure.

Authors:  R Todd Stravitz; Regina Bowling; Robert L Bradford; Nigel S Key; Sam Glover; Leroy R Thacker; Don A Gabriel
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

10.  Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).

Authors:  Jeffrey I Zwicker; Howard A Liebman; Kenneth A Bauer; Thomas Caughey; Federico Campigotto; Rachel Rosovsky; Simon Mantha; Craig M Kessler; Jonathan Eneman; Vidya Raghavan; Heinz-Joseph Lenz; Andrea Bullock; Elizabeth Buchbinder; Donna Neuberg; Bruce Furie
Journal:  Br J Haematol       Date:  2012-12-13       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.